Physician profile
Rachit Gupta
NPI 1669819629
$16,106.26
in general payments reported to CMS, 2019-2025
16 companies · $904 in 2025
The $904 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $13K · 2023: $1,795 · 2024: $770 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,398.04 | 2022-2025 | Da Vinci Surgical System |
| Davol INC. | $1,866.48 | 2022-2025 | Progel Applicator Spray Tips |
| Kls-Martin L.P. | $480.29 | 2021-2024 | |
| Atricure, INC. | $379.03 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Ethicon US, LLC | $191.27 | 2025 | Echelon; Endopath |
| Merck Sharp & Dohme LLC | $177.58 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| E.R. Squibb & Sons, L.L.C. | $156.82 | 2022-2024 | Opdivo |
| Medtronic, INC. | $119.44 | 2022 | |
| Genentech, INC. | $107.90 | 2023-2024 | Alecensa |
| Eisai INC. | $50.02 | 2024 | |
| Astellas Pharma US INC | $48.64 | 2025 | Padcev |
| Sumitomo Pharma America, INC. | $38.87 | 2025 | Orgovyx |
| Janssen Biotech, INC. | $35.97 | 2022-2025 | Erleada, Akeega, Balversa |
| Kerecis Limited | $22.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals LP | $20.19 | 2024 | Lynparza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| On Target Laboratories, INC | $13.14 | 2025 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.